Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016

BACKGROUND: The Centers for Disease Control and Prevention (CDC) currently recommends dual therapy with ceftriaxone and azithromycin for gonorrhea to ensure effective treatment and slow emergence of antimicrobial resistance. Since 2013, the prevalence of reduced azithromycin susceptibility increased...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Infect Dis
Hoofdauteurs: Katz, Alan R., Komeya, Alan Y., Kirkcaldy, Robert D., Whelen, A. Christian, Soge, Olusegun O., Papp, John R., Kersh, Ellen N., Wasserman, Glenn M., O’Connor, Norman P., O’Brien, Pamela S., Sato, Douglas T., Maningas, Eloisa V., Kunimoto, Gail Y., Tomas, Juval E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748320/
https://ncbi.nlm.nih.gov/pubmed/28549097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix485
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items